1
TITLE: Frequency and Prognostic Impact of ALK Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1)
AUTHORS: Bellini, Angela; Poetschger, Ulrike; Bernard, Virginie; Lapouble, Eve; Baulande, Sylvain; Ambros, Peter F.; Auger, Nathalie; Beiske, Klaus; Bernkopf, Marie; Betts, David R.; Bhalshankar, Jaydutt; Bown, Nick; de Preter, Katleen; Clement, Nathalie; Combaret, Valerie; de Mora, Jaime Font; George, Sally L.; Jimenez, Irene; Jeison, Marta; Marques, Barbara; Martinsson, Tommy; Mazzocco, Katia; Morini, Martina; Muehlethaler Mottet, Annick; Noguera, Rosa; Pierron, Gaelle; Rossing, Maria; Taschner Mandl, Sabine; Van Roy, Nadine; Vicha, Ales; Chesler, Louis; Balwierz, Walentyna; Castel, Victoria; Elliott, Martin; Kogner, Per; Laureys, Genevieve; Luksch, Roberto; Malis, Josef; Popovic Beck, Maja; Ash, Shifra; Delattre, Olivier; Valteau Couanet, Dominique; Tweddle, Deborah A.; Ladenstein, Ruth; Schleiermacher, Gudrun; ...More
PUBLISHED: 2021, SOURCE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 39, ISSUE: 30
INDEXED IN: WOS
2
TITLE: Influence of Surgical Excision on the Survival of Patients With Stage 4 High-Risk Neuroblastoma: A Report From the HR-NBL1/SIOPEN Study
AUTHORS: Keith Holmes; Ulrike Poetschger; Andrew D J Pearson; Sabine Sarnacki; Giovanni Cecchetto; Javier Gomez Chacon; Roly Squire; Enrique Freud; Adam Bysiek; Lucas E Matthyssens; Martin Metzelder; Tom Monclair; Jakob Stenman; Michal Rygl; Lars Rasmussen; Jean Marc Joseph; Sabine Irtan; Stefano Avanzini; Jan Godzinski; Kristin Bjornland; Martin Elliott; Roberto Luksch; Victoria Castel; Shifra Ash; Walentyna Balwierz; Genevieve Laureys; Ellen Ruud; Vassilios Papadakis; Josef Malis; Cormac Owens; Henrik Schroeder; Maja Beck Popovic; Toby Trahair; Ana Forjaz de Lacerda; Peter F Ambros; Mark N Gaze; Kieran McHugh; Dominique Valteau Couanet; Ruth Lydia Ladenstein; ...More
PUBLISHED: 2020, SOURCE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 38, ISSUE: 25
INDEXED IN: Scopus WOS
3
TITLE: Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable MYCN-Nonamplified Neuroblastomas. Report From the SIOPEN Biology Group on the LNESG Trials and a COG Validation Group
AUTHORS: Inge M Ambros; Gian Paolo Tonini; Ulrike Poetschger; Nicole Gross; Veronique Mosseri; Klaus Beiske; Ana P Berbegall; Jean Benard; Nick Bown; Huib Caron; Valerie Combaret; Jerome Couturier; Raffaella Defferrari; Olivier Delattre; Marta Jeison; Per Kogner; John Lunec; Barbara Marques; Tommy Martinsson; Katia Mazzocco; Rosa Noguera; Gudrun Schleiermacher; Alexander Valent; Nadine Van Roy; Eva Villamon; Dasa Janousek; Ingrid Pribill; Evgenia Glogova; Edward F Attiyeh; Michael D Hogarty; Tom F Monclair; Keith Holmes; Dominique Valteau Couanet; Victoria Castel; Deborah A Tweddle; Julie R Park; Sue Cohn; Ruth Ladenstein; Maja Beck Popovic; Bruno De Bernardi; Jean Michon; Andrew D J Pearson; Peter F Ambros; ...More
PUBLISHED: 2020, SOURCE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 38, ISSUE: 31
INDEXED IN: Scopus WOS
4
TITLE: EBMT Lessons from 40 Years of High Dose Chemotherapy (HDT) and Stem Cell Transplantation (SCT) In Neuroblastoma. A Report From the Paediatric Working Party
AUTHORS: Ruth Ladenstein; Ulrike Poetschger; Penelope Brock; Roberto Luksch; Victoria Castel; Shifra Ash; Vassilios Papadakis; Genevieve Laureys; Josef Malis; Walentyna Balwierz; Ellen Ruud; Per Kogner; Henrik Schroeder; Ana Forjaz de lacerda; Maja Beck Popovic; Pavel Bician; Miklos Garami; Evgenia Glogova; Dominique Valteau Couanet; Selim Corbacioglu;
PUBLISHED: 2020, SOURCE: BONE MARROW TRANSPLANTATION, VOLUME: 55, ISSUE: SUPPL 1
INDEXED IN: WOS
5
TITLE: Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
AUTHORS: Casali, PG; Bielack, S; Abecassis, N; Aro, HT; Bauer, S; Biagini, R; Bonvalot, S; Boukovinas, I; Bovee, JVMG; Brennan, B; Brodowicz, T; Broto, JM; Brugieres, L; Buonadonna, A; De Alava, E; Dei Tos, APD; Del Muro, XG; Dileo, P; Dhooge, C; Eriksson, M; Fagioli, F; Fedenko, A; Ferraresi, V; Ferrari, A; Ferrari, S; Frezza, AM; Gaspar, N; Gasperoni, S; Gelderblom, H; Gil, T; Grignani, G; Gronchi, A; Haas, RL; Hassan, B; Hecker Nolting, S; Hohenberger, P; Issels, R; Joensuu, H; Jones, RL; Judson, I; Jutte, P; Kaal, S; Kager, L; Kasper, B; Kopeckova, K; Krakorova, DA; Ladenstein, R; Le Cesne, A; Lugowska, I; Merimsky, O; Montemurro, M; Morland, B; Pantaleo, MA; Piana, R; Picci, P; Piperno Neumann, S; Pousa, AL; Reichardt, P; Robinson, MH; Rutkowski, P; Safwat, AA; Schoffski, P; Sleijfer, S; Stacchiotti, S; Strauss, SJ; Sundby S Hall; Unk, M; Van Coevorden, F; Van der Graaf, WTA; Whelan, J; Wardelmann, E; Zaikova, O; Blay, JY; ...More
PUBLISHED: 2018, SOURCE: ANNALS OF ONCOLOGY, VOLUME: 29
INDEXED IN: Scopus WOS
6
TITLE: Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial  Full Text
AUTHORS: Ruth Ladenstein; Ulrike Poetschger; Andrew D J Pearson; Penelope Brock; Roberto Luksch; Victoria Castel; Isaac Yaniv; Vassilios Papadakis; Genevieve Laureys; Josef Malis; Walentyna Balwierz; Ellen Ruud; Per Kogner; Henrik Schroeder; Ana Forjaz de Lacerda; Maja Beck Popovic; Pavel Bician; Miklos Garami; Toby Trahair; Adela Canete; Peter F Ambros; Keith Holmes; Mark Gaze; Guenter Schreier; Alberto Garaventa; Gilles Vassal; Jean Michon; Dominique Valteau Couanet; ...More
PUBLISHED: 2017, SOURCE: LANCET ONCOLOGY, VOLUME: 18, ISSUE: 4
INDEXED IN: WOS
7
TITLE: Risk factors in stage 4 neuroblastoma patients treated with Busulphan-Melphalan. Report from the European High Risk Neuroblastoma HR-NBL1/SIOPEN TRIAL  Full Text
AUTHORS: Ladenstein, R; Poetschger, U; Elliot, M; Luksch, R; Castel, V; Yaniv, I; Papadakis, V; Laureys, G; Malis, J; Balwierz, W; Ruud, E; Kogner, P; Schroeder, H; Forjaz F de lacerda; Beck Popovic, M; Bician, P; Garami, M; Trahair, T; Ambros, P; Holmes, K; Schreier, G; Gaze, M; Pearson, A; Valteau Couanet, D; ...More
PUBLISHED: 2016, SOURCE: 42nd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation in BONE MARROW TRANSPLANTATION, VOLUME: 51
INDEXED IN: WOS
8
TITLE: RISK FACTORS WITHIN THE EUROPEAN HIGH RISK NEUROBLASTOMA HR-NBL1/SIOPEN TRIAL  Full Text
AUTHORS: Ladenstein, R; Poetschger, U; Luksch, R; Brock, P; Castel, V; Yaniv, I; Papadakis, V; Laureys, G; Malis, J; Balwierz, W; Ruud, E; Kogner, P; Schroeder, H; Forjaz De Lacerda, AF; Beck Popovic, M; Bician, P; Garami, M; Trahair, T; Ambros, P; Holmes, K; Gaze, M; Pearson, ADJ; Valteau Couanet, D; ...More
PUBLISHED: 2014, SOURCE: 40th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation in BONE MARROW TRANSPLANTATION, VOLUME: 49
INDEXED IN: WOS
9
TITLE: MAJOR RESULTS FROM THE HR-NBL1/SIOPEN TRIAL FOR HIGH RISK NEUROBLASTOMA  Full Text
AUTHORS: Ruth Ladenstein; Ulrike Poetschger; Roberto Luksch; Penelope Brock; Victoria Castel; Isaac Yaniv; Vassilios Papadakis; Genevieve Laureys; Josef Malis; Walentyna Balwierz; Ellen Ruud; Per Kogner; Henrik Schroeder; Ana Forjaz De Lacerda; Maja Beck Popovic; Pavel Bician; Miklos Garami; Toby Trahair; Peter Ambros; Andrew D J Pearson; Dominique Valteau Couanet; ...More
PUBLISHED: 2012, SOURCE: PEDIATRIC BLOOD & CANCER, VOLUME: 59, ISSUE: 6
INDEXED IN: WOS
10
TITLE: Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study)  Full Text
AUTHORS: Schleiermacher, G; Michon, J; Ribeiro, A; Pierron, G; Mosseri, V; Rubie, H; Munzer, C; Benard, J; Auger, N; Combaret, V; Janoueix Lerosey, I; Pearson, A; Tweddle, DA; Bown, N; Gerrard, M; Wheeler, K; Noguera, R; Villamon, E; Canete, A; Castel, V; Marques, B; de lacerda, A; Tonini, GP; Mazzocco, K; Defferrari, R; de Bernardi, B; di Cataldo, A; van Roy, N; Brichard, B; Ladenstein, R; Ambros, I; Ambros, P; Beiske, K; Delattre, O; Couturier, J; ...More
PUBLISHED: 2011, SOURCE: BRITISH JOURNAL OF CANCER, VOLUME: 105, ISSUE: 12
INDEXED IN: Scopus WOS CrossRef
Página 1 de 2. Total de resultados: 18.